Lipidomics: New approaches to the studies of cell signaling and prospects of use in medicine

Bulletin of Experimental Biology and Medicine

Volumn 144, Issue 3, 2007, Pages 408-412

  Torkhovskaya, T I ^a   Khalilov, E M ^a   Korotaeva, A A ^a  

^a Federal Agency for Health Care and Social Development   (Russian Federation)

Author keywords

Cell signaling; Lipidomics; Lysophosphatide acid; Lysosphingolipids

Indexed keywords

CELL RECEPTOR; CYCLOSPORIN; FINGOLIMOD; GUANINE NUCLEOTIDE BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOGLYCERIDE; LYSOPHOSPHOLIPID; LYSOSPHINGOPHOSPHOLIPID; PHOSPHOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSYLPHOSPHORYLCHOLINE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BIOCHEMISTRY; CELL FUNCTION; CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG TARGETING; FRACTIONATION; GRAFT REJECTION; GYNECOLOGIC CANCER; HUMAN; LIPID ANALYSIS; LIPIDOMICS; MASS SPECTROMETRY; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS; SECOND MESSENGER; SIGNAL TRANSDUCTION;

BIOMEDICAL RESEARCH; GTP-BINDING PROTEINS; HUMANS; LIPIDS; LYSOPHOSPHOLIPIDS; MEDICINE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 37749001287     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0342-1     Document Type: Article

References (26)

1. E. V. Dyatlovitskaya and A. G. Kandyba, Biokhimiya, 71, 17-25 (2006).
2. N. V. Prokazova, N. D. Zvezdina, and A. A. Korotaeva, Ibid., 63, 38-46 (1998).
3. Adibhatla, J. F. Hatcher, and R. J. Dempsey, AAPS J., 8, No. 2, E314-E321 (2006).
4. N. Auge, M. Nikolova-Karakashian, S. Carpentier, et al., J. Biol. Chem., 274, 21,533-21,538 (1999).
5. L. T. Budnik and A. K. Mukhopadhyay, Biol. Reprod., 66, 859-865 (2002).
6. X. L. Chen, J. Y. Grey, S. Thomas, et al., Am. J. Physiol. Heart Circ. Physiol., 287, H1452-H1458 (2004).
7. J. Chun, E. J. Goetzl, T. Hla, et al., Pharmacol. Rev., 54, 265-269 (2002).
8. X. Fang, D. Gaudette, T. Furui, et al., Ann. N.Y. Acad. Sci., 905, 188-208 (2000).
9. E. J. Goetzl and S. An, FASEB J., 12, 1589-1598 (1998).
10. I. Gouni-Berthold and A. Sachinidis, Ibid., 16, 1477-1488 (2002).
11. X. Han, Front. Sci., 12, 2601-2615 (2007).
12. X. Han, J. Yang, H. Cheng, et al., Biochemistry, 44, No. 50, 16,684-16,694 (2005).
13. J. H. Kabarowski, K. Zhu, L. Q. Le, et al., Science, 293, 702-705 (2001).
14. V. E. Kagan, Y. Y. Tyurina, H. Bayir, et al., Biol. Interact., 163, No. 1-2, 15-28 (2006).
15. T. Levade, N. Auge, and R. J. Veldman, Circ. Res., 89, 857-968 (2001).
16. K. Liliom, G. Sun, M. Bunemann, et al., Biochem. J., 355, 189-197 (2001).
17. L. J. Pike, J. Lipid Res., 44, 655-667 (2003).
18. M. Pulfer and R. C. Murphy, Mass Spectrometry Reviews, 22, 332-364 (2003).
19. C. N. Serhan, S. Hong, and Y. Lu, AAPS J., 8, No. 2, E284-E297 (2006).
20. S. Spiegel and S. Milstein, J. Biol. Chem., 277, 25,851-25,854 (2002).
21. M. Umezu-Goto, J. Tanyi, J. Lahad, et al., J. Cell. Biochem., 92, No. 6, 1115-1140 (2004).
22. A. D. Watson, J. Lipid Res., 47, No. 10, 2101-2111 (2006).
23. M. R. Wenk, Nat. Rev. Drug Discov., 4, No. 7, 594-610 (2005).
24. Y. Yatomi, Curr. Pharm. Res., 12, 575-587 (2006).
25. K. Zhu, L. M. Baudhuin, and G. Hong, J. Biol. Chem., 276, 41 325-41 335 (2001).
26. D. M. zu Heringdorf, H. M. Himmel, and K. H. Jakobs, Biochim. Biophys. Acta, 1582, 178-189 (2002).